Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1976 1
1977 1
1978 1
1980 2
1981 3
1982 6
1983 2
1984 1
1985 3
1986 3
1987 2
1989 2
1991 1
1992 1
1993 3
1994 3
1995 1
1996 2
1997 4
1998 4
1999 2
2000 3
2001 1
2002 2
2003 3
2005 4
2006 10
2007 8
2008 3
2009 3
2010 6
2011 5
2012 7
2013 8
2014 7
2015 11
2016 12
2017 18
2018 20
2019 16
2020 23
2021 19
2022 23
2023 18
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Ogita M, Suwa S, Isawa T, Domei T, Yamaji K, Tatsushima S, Watanabe H, Ohya M, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 ACS Investigators. Watanabe H, et al. Among authors: ohya m. JAMA Cardiol. 2022 Apr 1;7(4):407-417. doi: 10.1001/jamacardio.2021.5244. JAMA Cardiol. 2022. PMID: 35234821 Free PMC article. Clinical Trial.
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators. Watanabe H, et al. Among authors: ohya m. JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145. JAMA. 2019. PMID: 31237644 Free PMC article. Clinical Trial.
Serial Optical Coherence Tomography Assessment of Coronary Atherosclerosis and Long-Term Clinical Outcomes.
Yamaji K, Kanenawa K, Morofuji T, Nishikawa R, Imada K, Kohjitani H, Watanabe H, Tazaki J, Taniwaki M, Koga S, Akashi R, Kubo S, Ohya M, Kikuchi T, Ohira H, Numasawa Y, Arikawa M, Iwama M, Kitai T, Kobayashi Y, Shiomi H, Tada T, Yamaji Y, Daidoji H, Ohtani H, Furukawa Y, Kadota K, Toyofuku M, Ando K, Ono K, Kimura T; PREDICTOR investigators. Yamaji K, et al. Among authors: ohya m. J Am Heart Assoc. 2024 Nov 5;13(21):e034458. doi: 10.1161/JAHA.123.034458. Epub 2024 Oct 22. J Am Heart Assoc. 2024. PMID: 39435729 Free PMC article.
Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.
Kanaoka K, Onoue K, Terasaki S, Nakano T, Nakai M, Sumita Y, Hatakeyama K, Terasaki F, Kawakami R, Iwanaga Y, Miyamoto Y, Saito Y; Japanese Registry of Fulminant Myocarditis Investigators. Kanaoka K, et al. Circulation. 2022 Nov 8;146(19):1425-1433. doi: 10.1161/CIRCULATIONAHA.121.058869. Epub 2022 Sep 27. Circulation. 2022. PMID: 36164974
Coronary-Artery Occlusion from Kawasaki's Disease.
Matsuura H, Ohya M. Matsuura H, et al. Among authors: ohya m. N Engl J Med. 2018 Dec 20;379(25):e42. doi: 10.1056/NEJMicm1804902. N Engl J Med. 2018. PMID: 30575487 Free article. No abstract available.
Severe Aortic Stenosis in Dialysis Patients.
Kawase Y, Taniguchi T, Morimoto T, Kadota K, Iwasaki K, Kuwayama A, Ohya M, Shimada T, Amano H, Maruo T, Fuku Y, Izumi C, Kitai T, Saito N, Minamino-Muta E, Kato T, Inada T, Inoko M, Ishii K, Komiya T, Hanyu M, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Kawase Y, et al. Among authors: ohya m. J Am Heart Assoc. 2017 Jul 14;6(7):e004961. doi: 10.1161/JAHA.116.004961. J Am Heart Assoc. 2017. PMID: 28710181 Free PMC article.
Multiple primary chordomas of the lung.
Ohya M, Yoshida K, Shimojo H, Shiina T. Ohya M, et al. Respir Med Case Rep. 2018 Aug 21;25:142-144. doi: 10.1016/j.rmcr.2018.08.012. eCollection 2018. Respir Med Case Rep. 2018. PMID: 30175034 Free PMC article.
Complex PCI and 1-year outcomes in the OPTIVUS-complex PCI study multivessel cohort.
Gohbara M, Hibi K, Morimoto T, Kirigaya H, Yamamoto K, Ono K, Shiomi H, Ohya M, Yamaji K, Watanabe H, Amano T, Morino Y, Takagi K, Honye J, Matsuo H, Abe M, Kadota K, Ando K, Nakao K, Sonoda S, Suwa S, Kawai K, Kozuma K, Nakagawa Y, Ikari Y, Nanasato M, Hanaoka K, Tanabe K, Hata Y, Akasaka T, Kimura T; OPTIVUS-Complex PCI investigators. Gohbara M, et al. Among authors: ohya m. Cardiovasc Interv Ther. 2025 Jul;40(3):516-526. doi: 10.1007/s12928-025-01110-z. Epub 2025 Apr 6. Cardiovasc Interv Ther. 2025. PMID: 40188401
254 results